Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Skok, K; Maccio, U; Martin, SD; Bräutigam, K. 
Tumor-Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers.
Cancer Med. 2025; 14(13): e71023
 Doi: 10.1002/cam4.71023
 [OPEN ACCESS]
Web of Science
PubMed
 FullText
FullText_MUG
FullText
FullText_MUG
 
- Leading authors Med Uni Graz
- 
Skok Kristijan
-  Altmetrics: 
-  Dimensions Citations: 
-  Plum Analytics: 
-  Scite (citation analytics): 
- Abstract:
- BACKGROUND: The growing success of cancer immunotherapies has led to significant advances in oncology. However, despite these promising developments, cancer-related mortality remains high for common cancer types such as breast and lower female genital tract cancers. METHOD: Here, we synthesize recent findings on the prognostic relevance of tumor-infiltrating lymphocytes (TILs) in breast, endometrial, tubo-ovarian, and vulvar cancer. Our analysis covers the relationship between TIL counts and density, immune cell subtype combinations, immunotherapy approaches, and patient outcomes. RESULTS: High TIL infiltration, especially CD8+ T-cells, generally correlates with improved outcomes such as in endometrial cancer (especially the POLE-ultramutated subgroup), invasive breast cancer, and ovarian epithelial tumors. However, in ductal carcinoma in situ (DCIS) of the breast, elevated TIL counts are linked to a worse prognosis. Ethnicity, the tumor microenvironment (TME), and molecular profiles further complicate the prognostic utility of TILs. CONCLUSIONS: TIL-based therapies have shown potential in personalized immunotherapy, particularly in recurrent, refractory ovarian cancer. Limited research on rarer gynecologic tumors hinders broader clinical applications.
- Find related publications in this database (using NLM MeSH Indexing)
- 
Humans - administration & dosage 
- 
Female - administration & dosage 
- 
Lymphocytes, Tumor-Infiltrating - immunology, metabolism 
- 
Breast Neoplasms - immunology, therapy, pathology, mortality 
- 
Tumor Microenvironment - immunology 
- 
Genital Neoplasms, Female - immunology, therapy, pathology, mortality 
- 
Prognosis - administration & dosage 
- 
Immunotherapy - methods
- Find related publications in this database (Keywords)
- 
breast cancer
- 
endometrial cancer
- 
fallopian tube
- 
immunotherapy
- 
ovarian cancer
- 
review
- 
tumor microenvironment (TME)
- 
tumor-infiltrating lymphocytes (TILs)
- 
vulvar cancer